FDA DEVICE FACTS
Powder Free Nitrile Examination Gloves Tested For Use With Chemotherapy Drugs Labeling Claim (White); Powder Free Nitrile Examination Gloves Tested For Use With Chemotherapy Drugs Labeling Claim (Blue)
Comfort Rubber Gloves Industries Sdn. Bhd.
FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。
Indications for use
The Powder Free Nitrile Examination Gloves Tested for Use with Chemotherapy D rugs Labeling Claim (White) is a specialty medical glove which is a disposable device intended for medical purpose that is worn on the examiner’s h and or finger to prevent contamination between examiner and patient. In addition these gloves are worn to protect the wearer against exposure to chemotherapy drugs. Tested for use with chemotherapy drugs. Tested chemotherapy drugs are as follows:
Average Breakthrough Detection Time (minutes)
Cisplatin, 1.0 mg/ml ≥240 Cyclophosphamide (Cytoxan), 20.0 mg/ml ≥240 Dacarbazine (DTIC), 10.0 mg/ml ≥240 Doxorubicin Hydrochloride, 2.0 mg/ml ≥240 Etoposide (Toposar), 20.0 mg/ml ≥240 Fluorouracil, 50.0 mg/ml ≥240 Paclitaxel (Taxol), 6.0 mg/ml ≥240 Carmustine (BCNU) 3.3 mg/ml 24.0 (mins) Thiotepa 10.0 mg/ml 54.9 (mins)
Please note that the following drugs have extremely low permeation time for:
Carmustine (BCNU) 3.3 mg/ml – 24.0 (mins) Thiotepa 10.0 mg/ml – 54.9 (mins) Powder Free Nitrile Examination Gloves Tested for Use with Chemotherapy Drugs Labeling Claim (Blue and White) Attachment 17 The Powder Free Nitrile Examination Gloves Tested for Use with Chemotherapy D rugs Labeling Claim (Blue) is a specialty medical glove which is a disposable device intended for medical purpose that is worn on the examiner’s h and or finger to prevent contamination between examiner and patient. In addition these gloves are worn to protect the wearer against exposure to chemotherapy drugs. Tested for use with chemotherapy drugs. Tested chemotherapy drugs are as follows:
Average Breakthrough Detection Time (minutes)
Cisplatin, 1.0 mg/ml ≥240 Cyclophosphamide (Cytoxan), 20.0 mg/ml ≥240 Dacarbazine (DTIC), 10.0 mg/ml ≥240 Doxorubicin Hydrochloride, 2.0 mg/ml ≥240 Etoposide (Toposar), 20.0 mg/ml ≥240 Fluorouracil, 50.0 mg/ml ≥240 Paclitaxel (Taxol), 6.0 mg/ml ≥240 Carmustine (BCNU) 3.3 mg/ml 18.2 (mins) Thiotepa 10.0 mg/ml 57.3 (mins)
Please note that the following drugs have extremely low permeation time for:
Carmustine (BCNU) 3.3 mg/ml – 18.2 (mins) Thiotepa 10.0 mg/ml – 57.3 (mins)
Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。
OFFICIAL FDA SOURCES
FDA Record and Public Document Status
Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。